Cerebral angiography is a medical imaging technique used to visualize the arteries and veins in the brain and neck. It is a minimally invasive procedure involving the insertion of a catheter into the femoral artery in the groin and guiding it up to the arteries supplying blood to the brain. Dye is then injected through the catheter and multiple X-ray images are taken to diagnose conditions like aneurysms, arteriovenous malformations, brain tumors and arteriosclerosis. It helps physicians understand the blood flow and identify areas of narrowing or blockage.

The global cerebral angiography market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The rising prevalence of neurological disorders such as brain aneurysms, arterial venous malformations and ischemic stroke is a key factor fueling the growth of the Global Cerebral Angiography Market Size. Neurological conditions affect millions of people globally and cerebral angiography plays a vital role in their diagnosis. For instance, according to the Brain Aneurysm Foundation, an estimated 6 million Americans have an unruptured brain aneurysm. Better understanding of the vascular system using cerebral angiography helps in planning effective treatment strategies for these patients. Moreover, technological advancements in angiography equipment such as the introduction of flat panel detectors and 3D reconstruction software are enabling higher resolution imaging and improved visualization of vascular anatomy. This is increasing the adoption of the procedure and driving the market growth over the forecast period.

SWOT Analysis

Strength: Cerebral angiography is a minimally invasive imaging technique that allows clear visualization of the brain's blood vessels. It carries minimal risks such as bleeding or infection at the injection site. Cerebral angiography can help diagnose conditions such as aneurysms, arteriovenous malformations, carotid artery stenosis and help plan for treatments such as aneurysm coiling or bypass surgery.

Weakness: Cerebral angiography requires inserting a catheter into an artery, usually in the groin, which carries risks of damage to blood vessels or complications from anesthesia. Some patients may also experience nausea, vomiting, back pain, headache or groin pain after the procedure. The availability of newer non-invasive imaging techniques such as CT angiography and MRI angiography have also reduced the need for invasive cerebral angiography in some clinical settings.

Opportunity: The rising incidence of cerebrovascular diseases worldwide due to risk factors such as hypertension, diabetes and lack of physical activity is expected to drive the demand for accurate diagnostic tools. Cerebral angiography remains the gold standard for investigating many complex cerebrovascular disorders and helps in proper treatment planning. Technological advancements improving imaging quality and safety are expanding its clinical applications.

Threats: Restricted reimbursement policies in some regions hamper the adoption of high-end angiography devices. The availability of non-invasive imaging alternatives reduces dependence on cerebral angiography, limiting opportunities for market players. Stringent regulatory approval processes and compliance add to operational costs.

Key Takeaways

The global cerebral angiography market is expected to witness high growth in the forecast period of 2023 to 2030 at a CAGR of 6.1% to reach a market size of US$ 14.96 billion by 2030 from US$ 10.33 billion in 2023.

Regional analysis: North America is currently the largest as well as the fastest growing regional market for cerebral angiography. This is attributed to the rising incidence of cerebrovascular diseases and presence of major market players in the region. However, Asia Pacific region is expected to offer lucrative growth opportunities owing to growing medical tourism, increasing healthcare investments and rapid economic development in countries such as China and India.

Key players:

Key players operating in the cerebral angiography market include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, and Cook Medical LLC. These players are focusing on new product launches and strategic collaborations to strengthen their market presence.

Get More Insights On This Topic: https://www.trendingwebwire.com/cerebral-angiography-market-analysis-growth-forecast-outlook-2023-2030/